Predictive value of the Lung Immune Prognostic Index (LIPI) in locally advanced non-small-cell lung cancer (NSCLC) patients treated with concurrent chemoradiotherapy (CCRT) in the multicenter retrospective study.

被引：0
|
作者：
Oya, Yuko
Saito, Go
Tamiya, Akihiro
Kawachi, Hayato
Fujimoto, Daichi
Iwasawa, Shunichiro
Suzuki, Hidekazu
Niitsu, Takayuki
Matsumoto, Hirotaka
Miyauchi, Eisaku
Yokoi, Takashi
Mitsui, Miho
Uenami, Takeshi
Sakata, Yoshihiko
Nakachi, Ichiro
Okada, Asuka
Hara, Satoshi
Teraoka, Shunsuke
Kokubo, Masaki
机构：
[1] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi, Japan
[2] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Japan
[3] Natl Hosp Org Kinki Chuo Chest Med Ctr, Dept Internal Med, Sakai, Osaka, Japan
[4] Osaka Int Canc Inst, Dept Thorac Oncol, Osaka, Japan
[5] Gen Hosp, Kobe City Med Ctr, Dept Resp Med, Kobe, Hyogo, Japan
[6] Chiba Univ, Dept Med Oncol, Chiba, Japan
[7] Osaka Habikino Med Ctr, Dept Thorac Oncol, Habikino, Japan
[8] Osaka Gen Med Ctr, Dept Resp Med, Osaka, Japan
[9] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Resp Med, Amagasaki, Hyogo, Japan
[10] Tohoku Univ Hosp, Dept Resp Med, Sendai, Miyagi, Japan
[11] Hyogo Coll Med, Dept Thorac Oncol, Nishinomiya, Hyogo, Japan
[12] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan
[13] Natl Hosp Org Osaka Toneyama Med Ctr, Dept Thorac Oncol, Osaka, Japan
[14] Saiseikai Kumamoto Hosp, Div Resp Med, Kumamoto, Japan
[15] Saiseikai Utsunomiya Hosp, Internal Med, Pulm Div, Utsunomiya, Tochigi, Japan
[16] Saiseikai Suita Hosp, Dept Resp Med, Osaka, Japan
[17] Itami City Hosp, Dept Resp Med, Osaka, Japan
[18] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan
[19] Kobe City Med Ctr, Gen Hosp, Dept Radiat Oncol, Kobe, Hyogo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21076
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy (CRT) in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
    Tanaka, K.
    Okamoto, I.
    Yamamoto, N.
    Hattori, Y.
    Masuda, N.
    Nishio, M.
    Takeda, K.
    Seto, T.
    Nishimura, Y.
    Nakagawa, K.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S605 - S605
  • [32] Association of Cardiac Dose with Cardiac Events and Survival for Locally Advanced Non -Small Cell Lung Cancer (LA-NSCLC) Treated with Concurrent Chemoradiotherapy (cCRT) in the Era of Immune Checkpoint Inhibitor (ICI) Consolidation
    Yegya-Raman, N.
    Lee, S. H.
    Friedes, C.
    Iocolano, M.
    Kim, K. N.
    Duan, L.
    Li, B.
    Sun, L.
    Cohen, R.
    Cengel, K. A.
    Levin, W. P.
    Langer, C.
    Aggarwal, C.
    Ky, B.
    O'Quinn, R. P.
    Zou, W.
    Teo, K.
    Deasy, J. O.
    Xiao, Y.
    Feigenberg, S. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S169 - S170
  • [33] Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy?
    Komurcuoglu, Berna
    Vatansever, Yelda
    Korkmaz, Esra
    Evkan, Aysen
    Yalniz, Enver
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [34] Palifermin Reduces Dysphagia in Patients with Locally-advanced Unresected Non-small-cell Lung Cancer Undergoing Concurrent Chemoradiotherapy
    Schuette, W.
    Krzakowski, M.
    Massuti, B.
    Otterson, G.
    Lizambri, R.
    Wei, H.
    Berger, D.
    Chen, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S114 - S114
  • [35] IMPACT OF PRETRETMENT LEUKOCYTOSIS ON PROGNOSIS IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CHEMORADIOTHERAPY
    Topkan, Erkan
    Parlak, Cem
    Guler, Ozan C.
    Pehlivan, Berrin
    Selek, Ugur
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S412 - S412
  • [36] Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Rogado, J.
    Pacheco-Barcia, V.
    Fenor De la Maza, M. D.
    Serra, J. M.
    Toquero, P.
    Vera, B.
    Obispo, B.
    Mondejar, R.
    Ballesteros, A.
    Donnay, O.
    Colomer, R.
    Sanchez-Torres, J. M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1915 - S1916
  • [37] IMPACT OF PRETRETMENT LEUKOCYTOSIS ON PROGNOSIS IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CHEMORADIOTHERAPY
    Topkan, Erkan
    Parlak, Cem
    Pehlivan, Berrin
    Ozyilkan, Ozgur
    Selek, Ugur
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S556 - S556
  • [38] Predictive and prognostic value of de novo MET expression in patients with advanced non-small-cell lung cancer
    Li, Anna
    Niu, Fei-Yu
    Han, Jie-Fei
    Lou, Na-Na
    Yang, Jin-Ji
    Zhang, Xu-Chao
    Zhou, Qing
    Xie, Zhi
    Su, Jian
    Zhao, Ning
    Huang, Ying
    Wu, Yi-Long
    LUNG CANCER, 2015, 90 (03) : 375 - 380
  • [39] Prognostic Significance of Weight Gain During Definitive Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer
    Sher, David J.
    Gielda, Benjamin T.
    Liptay, Michael J.
    Warren, William H.
    Batus, Marta
    Fidler, Mary Jo
    Garg, Shalini
    Bonomi, Philip
    CLINICAL LUNG CANCER, 2013, 14 (04) : 370 - 375
  • [40] Lung Immune Prognostic Index (LIPI) in Advanced NSCLC Patients Treated with Immunotherapy, Chemotherapy and both Combined Upfront.
    Blanc-Durand, F.
    Mielgo Rubio, X.
    Auclin, E.
    Ponce-Aix, S.
    Lopez Castro, R.
    Nadal, E.
    Planchard, D.
    Routy, B.
    Hendriks, L.
    Sullivan, I.
    Dempsey, N.
    Pilotto, S.
    Aboubakar, F.
    Pinato, D. J.
    Castonguay, M.
    Rodriguez, A.
    Amores, A.
    Bluthgen, M. V.
    Duchemann, B.
    Cruz Castellano, P.
    Aguado De La Rosa, C.
    Sereno Moyano, M.
    Ruffinelli, J.
    Lopez, G.
    Caramella, C.
    Besse, B.
    Mezquita, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S205 - S206
12345